<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03447639</url>
  </required_header>
  <id_info>
    <org_study_id>2018-001</org_study_id>
    <nct_id>NCT03447639</nct_id>
  </id_info>
  <brief_title>Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal</brief_title>
  <official_title>A Randomized Trial of Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal to Reduce Bacteriuria and Catheter-Associated Urinary Tract Infections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>William Beaumont Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>William Beaumont Hospitals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Over the last decade, there has been great emphasis on reducing the incidence of
      hospital-acquired infections, including catheter-associated UTI (CAUTI). This study will
      evaluate the effectiveness of Betadine irrigation solution (2% povidone-iodine) instilled
      into the bladder immediately prior to indwelling catheter removal to decrease the risk of
      subsequent bacteriuria, leading to decreased rates of NHSN defined CAUTI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Indwelling urinary catheters are routinely used in the care of hospitalized patients for a
      variety of reasons, including monitoring of urine output in critically ill patients, relief
      of urinary obstruction, and prevention of contamination of decubitus ulcers. Bacteriuria
      increases by 3-10% each day a catheter is left in place, meaning that by 30 days, generally
      100% of patients with indwelling catheters will have bacteria in their urine. The majority of
      these people do not have urinary tract infections (UTIs), they are merely colonized and do
      not require treatment.

      To define a standard (and ultimately to compare hospitals against each other), a surveillance
      definition for CAUTI has been developed by the National Healthcare Safety Network (NHSN).
      While useful for surveillance, the definition does not correlate with clinical UTIs, leading
      to over diagnosis and over-reporting of UTIs (in other words, those with merely bladder
      colonization being diagnosed as having a UTI). Despite continuing progress in standard
      methods of reducing infection rates (including decreasing the number of catheters inserted,
      ensuring proper catheter maintenance, and removing catheters when no long necessary) there
      continue to be unacceptably high rates of CAUTIs.

      A single dose of povidone-iodine prior to catheter removal seems a novel and promising
      practice for several reasons. First, we suspect it will be helpful in reducing rates of NHSN
      defined CAUTI, as these are still diagnosed for 2 days after the catheter is removed. Second,
      using multiple doses of povidone-iodine would be inadvisable, since we suspect bacteria over
      time would become resistant even to this antiseptic. Third, we suspect use of an antiseptic
      is preferable to an antibacterial for preventing further antimicrobial resistance
      development. Finally, use of this method, as opposed to the suggested use of systemic
      antibiotics at time of removal, is potentially preferable from the downstream standpoint of
      less antimicrobial resistance and reduced risk of Clostridium difficile infection.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of Patient Enrollment
  </why_stopped>
  <start_date type="Actual">March 29, 2018</start_date>
  <completion_date type="Actual">October 22, 2018</completion_date>
  <primary_completion_date type="Actual">October 18, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>2 arm parallel study with 1 to 1 randomization</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnosis of Urinary Tract Infection (UTI)</measure>
    <time_frame>48-72 hours after catheter removal</time_frame>
    <description>Per NHSN defined catheter associated UTI (CAUTI) criteria</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnosis of UTI at 7 Days</measure>
    <time_frame>7 days after catheter removal</time_frame>
    <description>Per National Healthcare Safety Network (NHSN) defined CAUTI criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnosis of UTI at 28 Days</measure>
    <time_frame>28 days after catheter removal</time_frame>
    <description>Per NHSN defined CAUTI criteria</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Catheter; Infection (Indwelling Catheter)</condition>
  <condition>Catheter Infection</condition>
  <condition>Catheter-Related Infections</condition>
  <condition>Catheter Bacteraemia</condition>
  <condition>Urinary Tract Infections</condition>
  <arm_group>
    <arm_group_label>Povidone-Iodine Irrigation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bladder irrigation with 2% povidine-iodine irrigation immediately prior to catheter removal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Catheter removal with no bladder irrigation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Povidone-iodine irrigation</intervention_name>
    <description>Single dose, 60 cc of 2% povidone-iodine indwelling for 10 minutes prior to catheter removal using aseptic technique</description>
    <arm_group_label>Povidone-Iodine Irrigation</arm_group_label>
    <other_name>Betadine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Provide written informed consent and the willingness and ability to comply with all
             aspects of study requirements

          2. Male

          3. Inpatients â‰¥ 18 years of age with an indwelling catheter in place for at least 5 days
             with a plan for removal

        Exclusion Criteria:

          1. Patients planned for discharge with an indwelling catheter in place

          2. Patients unable to report urinary symptoms accurately

          3. Patients with hyper-sensitivity or allergic reaction to Betadine, iodine, shellfish or
             other related compounds

          4. Clinical signs or symptoms of urinary tract infection at the time of consent

          5. Patients currently being treated for UTI

          6. Patients currently taking any antibiotic medication, other than vancomycin, linezolid,
             daptomycin, clindamycin, or metronidazole.

          7. Patients already taking medications known to potentially irritate the bladder, such
             as, but not limited to, cyclophosphamide, ifosfamide, and other chemotherapeutic
             agents

          8. Patients with history of bladder cancer, pelvic radiation or interstitial cystitis

          9. Patients unable to comply with study requirements

         10. Any other condition which, per investigators' judgment, may increase patient risk
             and/or impede the reliability of study data
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jay Hollander, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>William Beaumont Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>February 8, 2018</study_first_submitted>
  <study_first_submitted_qc>February 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2018</study_first_posted>
  <results_first_submitted>April 4, 2019</results_first_submitted>
  <results_first_submitted_qc>April 23, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">April 24, 2019</results_first_posted>
  <last_update_submitted>January 9, 2020</last_update_submitted>
  <last_update_submitted_qc>January 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>William Beaumont Hospitals</investigator_affiliation>
    <investigator_full_name>Jay Hollander MD</investigator_full_name>
    <investigator_title>Attending Urologist</investigator_title>
  </responsible_party>
  <keyword>Catheter associated UTI</keyword>
  <keyword>Povidine iodine</keyword>
  <keyword>Bladder Irrigation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Urinary Tract Infections</mesh_term>
    <mesh_term>Bacteremia</mesh_term>
    <mesh_term>Catheter-Related Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Povidone-Iodine</mesh_term>
    <mesh_term>Povidone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 25, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/39/NCT03447639/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>August 2, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/39/NCT03447639/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were recruited from the inpatient units of the hospital.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Povidone-Iodine Irrigation</title>
          <description>Bladder irrigation with 2% povidine-iodine irrigation immediately prior to catheter removal
Povidone-iodine irrigation: Single dose, 60 cc of 2% povidone-iodine indwelling for 10 minutes prior to catheter removal using aseptic technique</description>
        </group>
        <group group_id="P2">
          <title>Standard of Care</title>
          <description>Catheter removal with no bladder irrigation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0">No patients were randomized to the Povidone-Iodine irrigation arm</participants>
                <participants group_id="P2" count="3">3 patients were randomized to the Standard of Care arm.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0">No patients were randomized to the Povidone-Iodine irrigation arm</participants>
                <participants group_id="P2" count="1">2 patients were withdrawn because their catheters had to be re-inserted.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>No patients were randomized to the Povidone-Iodine arm</population>
      <group_list>
        <group group_id="B1">
          <title>Povidone-Iodine Irrigation</title>
          <description>Bladder irrigation with 2% povidine-iodine irrigation immediately prior to catheter removal
Povidone-iodine irrigation: Single dose, 60 cc of 2% povidone-iodine indwelling for 10 minutes prior to catheter removal using aseptic technique</description>
        </group>
        <group group_id="B2">
          <title>Standard of Care</title>
          <description>Catheter removal with no bladder irrigation</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="0"/>
            <count group_id="B2" value="3"/>
            <count group_id="B3" value="3"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Collected from the medical record</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="3"/>
                    <count group_id="B3" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="3"/>
                    <count group_id="B3" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="3"/>
                    <count group_id="B3" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Presence of urinary tract infection</title>
          <description>Positive urinary tract infection (UTI) is defined as a positive urinalysis, culture and patient reported UTI symptoms.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="3"/>
                    <count group_id="B3" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Diagnosis of Urinary Tract Infection (UTI)</title>
        <description>Per NHSN defined catheter associated UTI (CAUTI) criteria</description>
        <time_frame>48-72 hours after catheter removal</time_frame>
        <population>Patients with an indwelling catheter meeting the study eligibility criteria</population>
        <group_list>
          <group group_id="O1">
            <title>Povidone-Iodine Irrigation</title>
            <description>Bladder irrigation with 2% povidine-iodine irrigation immediately prior to catheter removal
Povidone-iodine irrigation: Single dose, 60 cc of 2% povidone-iodine indwelling for 10 minutes prior to catheter removal using aseptic technique</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>Catheter removal with no bladder irrigation</description>
          </group>
        </group_list>
        <measure>
          <title>Diagnosis of Urinary Tract Infection (UTI)</title>
          <description>Per NHSN defined catheter associated UTI (CAUTI) criteria</description>
          <population>Patients with an indwelling catheter meeting the study eligibility criteria</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diagnosis of UTI at 7 Days</title>
        <description>Per National Healthcare Safety Network (NHSN) defined CAUTI criteria</description>
        <time_frame>7 days after catheter removal</time_frame>
        <population>Study terminated due to low enrollment</population>
        <group_list>
          <group group_id="O1">
            <title>Povidone-Iodine Irrigation</title>
            <description>Bladder irrigation with 2% povidine-iodine irrigation immediately prior to catheter removal
Povidone-iodine irrigation: Single dose, 60 cc of 2% povidone-iodine indwelling for 10 minutes prior to catheter removal using aseptic technique</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>Catheter removal with no bladder irrigation</description>
          </group>
        </group_list>
        <measure>
          <title>Diagnosis of UTI at 7 Days</title>
          <description>Per National Healthcare Safety Network (NHSN) defined CAUTI criteria</description>
          <population>Study terminated due to low enrollment</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diagnosis of UTI at 28 Days</title>
        <description>Per NHSN defined CAUTI criteria</description>
        <time_frame>28 days after catheter removal</time_frame>
        <population>Study terminated due to low enrollment</population>
        <group_list>
          <group group_id="O1">
            <title>Povidone-Iodine Irrigation</title>
            <description>Bladder irrigation with 2% povidine-iodine irrigation immediately prior to catheter removal
Povidone-iodine irrigation: Single dose, 60 cc of 2% povidone-iodine indwelling for 10 minutes prior to catheter removal using aseptic technique</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>Catheter removal with no bladder irrigation</description>
          </group>
        </group_list>
        <measure>
          <title>Diagnosis of UTI at 28 Days</title>
          <description>Per NHSN defined CAUTI criteria</description>
          <population>Study terminated due to low enrollment</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>28 days; from study enrollment through the study completion</time_frame>
      <desc>No patients were enrolled in the povidone-iodine arm of the study</desc>
      <group_list>
        <group group_id="E1">
          <title>Povidone-Iodine Irrigation</title>
          <description>Bladder irrigation with 2% povidine-iodine irrigation immediately prior to catheter removal
Povidone-iodine irrigation: Single dose, 60 cc of 2% povidone-iodine indwelling for 10 minutes prior to catheter removal using aseptic technique</description>
        </group>
        <group group_id="E2">
          <title>Standard of Care</title>
          <description>Catheter removal with no bladder irrigation</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director of Urology Research</name_or_title>
      <organization>Beaumont Hospital</organization>
      <phone>248.551.0804</phone>
      <email>Deborah.Hasenau@Beaumont.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

